| 1 |
34725737 | How does nintedanib overcome cancer drug-resistant mutation of RET protein-tyrosine kinase: insights from molecular dynamics simulations. | 2021 Nov 2 |
3 |
| 2 |
31118272 | Structural basis of resistance of mutant RET protein-tyrosine kinase to its inhibitors nintedanib and vandetanib. | 2019 Jul 5 |
14 |
| 3 |
29908090 | Drug resistance profiles of mutations in the RET kinase domain. | 2018 Sep |
1 |
| 4 |
26622180 | Clinical development of nintedanib for advanced non-small-cell lung cancer. | 2015 |
2 |
| 5 |
26677336 | Profile of nintedanib in the treatment of solid tumors: the evidence to date. | 2015 |
2 |
| 6 |
25012508 | Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. | 2014 Jul 11 |
1 |